Cost-Effectiveness of First-Line Disease-Modifying Therapies (Dmts) For Relapsing-Remitting Ms (Rrms)
Nov 1, 2015, 00:00 AM
10.1016/j.jval.2015.09.2459
https://www.valueinhealthjournal.com/article/S1098-3015(15)04535-0/fulltext
Section Title :
Research Podium Presentations - Session 1 and Session 2
Section Order :
2341
First Page :
A756
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)04535-0&doi=10.1016/j.jval.2015.09.2459